Register Login
Register to leave comments
  • News bot March 10, 2026, 8:40 p.m.

    📋 VTV THERAPEUTICS INC. (VTVT) - Clinical Trial Update

    Filing Date: 2026-03-10

    Accepted: 2026-03-10 16:37:42

    Event Type: Clinical Trial Update

    Event Details:

    VTV THERAPEUTICS INC. (VTVT) Announces Clinical Trial Update VTV THERAPEUTICS INC. (VTVT) provided an update on its clinical development programs. Clinical Development Highlights:
    • Clinical Stage: CLINICAL TRIAL
    • Collaboration: TARGET
      • Targeting hepatic glucokinase to treat diabetes with TTP399, a hepatoselective glucokinase activator. Science Translational Medicine. 2019
      • targeting reduced oxidative stress and inflammation HPP971/HPP3033

    🔬 Clinical Development Pipeline (VTV THERAPEUTICS INC.):

    Product Type Development Stage Therapeutic Area Source
    TTP399 DRUG Phase PHASE1 Diabetes Mellitus, Type 1 ClinicalTrials.gov
    TTP273 DRUG Phase PHASE2 Type 2 Diabetes Mellitus ClinicalTrials.gov
    Placebo DRUG Phase PHASE3 Diabetes Mellitus, Type 1 ClinicalTrials.gov
    GK1-399 (formerly TTP399) DRUG Phase PHASE1 Type 2 Diabetes Mellitus ClinicalTrials.gov
    Cadisegliatin 800 mg BID DRUG Phase PHASE3 Diabetes Mellitus, Type 1 ClinicalTrials.gov
    Cadisegliatin 800 mg QD DRUG Phase PHASE3 Diabetes Mellitus, Type 1 ClinicalTrials.gov
    MC2-25 vehicle DRUG Phase PHASE2 Vulvar Lichen Sclerosus ClinicalTrials.gov
    MC2-25 cream DRUG Phase PHASE2 Vulvar Lichen Sclerosus ClinicalTrials.gov
    TTP889 DRUG Phase PHASE2 Venous Thromboembolism ClinicalTrials.gov
    TTP607 DRUG Phase PHASE1 Advanced Cancers ClinicalTrials.gov
    TTP435 DRUG Phase PHASE2 Obesity ClinicalTrials.gov
    TTP4000 DRUG Phase PHASE1 Alzheimer's Disease ClinicalTrials.gov
    TTP054 DRUG Phase PHASE2 Type 2 Diabetes Mellitus ClinicalTrials.gov
    Sitagliptin 100 mg DRUG Phase PHASE2 Diabetes Mellitus, Type 2 ClinicalTrials.gov
    TTP399 800 mg DRUG Phase PHASE2 Diabetes Mellitus, Type 2 ClinicalTrials.gov
    TTP399 400 mg DRUG Phase PHASE2 Diabetes Mellitus, Type 2 ClinicalTrials.gov
    Azeliragon 5mg DRUG Phase PHASE3 Alzheimer's Disease ClinicalTrials.gov
    Azeliragon DRUG Phase PHASE3 Alzheimer's Disease ClinicalTrials.gov
    Placebo Oral Tablet DRUG Phase PHASE1 Diabetes Mellitus, Type 1 ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: VTV THERAPEUTICS INC.
    • Ticker Symbol: VTVT

Search

News categories